Radar › Screener › CHRS

CHRS

Coherus Oncology, Inc.
CHRS stock: dilution — what the SEC filings say, updated every weekday morning.
Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1512762) · 5 signals · 1 setups · updated Sep 22, 2026

What the filings say Pressure ▼

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.

Radar 75 (high attention) · dilution pressure high · listing risk low · governance risk low · runway 9.2 mo · strongest signal: Offering (424B) (Aug 28, 2026)

What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

Get tomorrow's read on CHRS — free
One email every weekday morning: what changed across CHRS and ~1,400 other microcaps, every claim linked to the filing.
75Radar · attention score (0–100)
79Dilution pressure · financing + balance sheet
0Listing risk · exchange standards
0Governance risk · reporting, auditor, going concern

Setups

Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.

Forced-raise setup Pressure ▼ strength 0.80

The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (runway 6–12 months) coexists with live selling machinery (atm program, offering (424b)). Base case is a discounted raise; the question is when, not if.

Would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
Would invalidate: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
ATM programRunway 6–12 monthsOffering (424B)

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on CHRS
Alerts
One email the morning CHRS files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for CHRS back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 892 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$82.9Mcash + short-term investments as of Jun 30, 2026
9.2 moestimated runway (annualized 180-day YTD operating cash flow [companyfacts])
$60.8Mstockholders' equity as of Jun 30, 2026
$81.9Mpublic float (10-K cover)
154.5Mshares outstanding as of Jul 31, 2026 · was 154.2M Apr 30, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 84 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Aug 28, 2026▼ Offering (424B) 424B5 prospectus supplement 2026-08-28; 3 prior 424B filings in 12m filing 47
Aug 28, 2026▼ ATM program “atm” language in 8-K (8-K) filed 2026-08-28 filing 40
Aug 28, 2026▼ ATM program “atm” language in 424B5 (424B5) filed 2026-08-28 filing 40
Aug 28, 2026▼ Offering (424B) 424B3 prospectus supplement 2026-08-28; 3 prior 424B filings in 12m filing 27
Jun 30, 2026▼ Runway 6–12 months ~9.2 months runway: liquidity $186,551,000 (cash $82,923,000 + investments $103,628,000) as of 2026-06-30, burn $243,284,667/yr (annualized 180-day YTD operating cash flow [companyfacts]) filing 22

Other forced raise setups

SDST Stardust Power Inc. · GOVX GeoVax Labs, Inc. · MYSZ My Size, Inc. · SNTI Senti Biosciences Holdings, · GCTK Glucotrack, Inc. · SOAR Volato Group, Inc. · screener →

Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans